InflaRx
IFRX
27 hedge funds and large institutions have $7.63M invested in InflaRx in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 13 closing their positions.
500% more call options, than puts
Call options by funds: $6K | Put options by funds: $1K
2.68% less ownership
Funds ownership: 14.59% → 11.9% (-2.7%)
16% less funds holding
Funds holding: 32 → 27 (-5)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
36% less capital invested
Capital invested by funds: $12M → $7.63M (-$4.35M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$71K |
| 2 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$69K |
| 3 |
Millennium Management
New York
|
+$45.4K |
| 4 |
V
Veritable
Wilmington,
Delaware
|
+$25.9K |
| 5 |
Morgan Stanley
New York
|
+$19.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$639K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$603K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$444K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$177K |
| 5 |
Renaissance Technologies
New York
|
-$150K |
IFRX Hedge Fund Activity: Q2 2022 in Review
27 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2022, worth a combined $7.63M — down 36% from $12M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of IFRX and 8 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $71K. The largest seller was Ikarian Capital, exiting entirely with an estimated $639K sold.
- 27 institutional investors held InflaRx (IFRX) as of Q2 2022, down from 32 in Q1 2022.
- Funds reported $7.63M of InflaRx stock for Q2 2022, down 36% quarter-over-quarter.
- 8 funds opened new InflaRx positions in Q2 2022 and 13 closed out, a net change of -5 holders.
- The largest InflaRx buyer in Q2 2022 was Susquehanna International Group, an estimated $71K added.
- The largest InflaRx seller in Q2 2022 was Ikarian Capital, an estimated $639K sold.
Based on aggregated 13F filings for Q2 2022.